← Back to headlines
Barclays Reaffirms Equal Weight Rating for uniQure (QURE)
Barclays has reaffirmed its 'Equal Weight' rating for uniQure (QURE), maintaining its neutral outlook on the biotechnology company's stock performance.
1 Apr, 09:35 — 1 Apr, 09:35
Sources
Showing 1 of 1 sources
